» Articles » PMID: 12235157

Intracellular Calcium and Myosin Isoform Transitions. Calcineurin and Calcium-calmodulin Kinase Pathways Regulate Preferential Activation of the IIa Myosin Heavy Chain Promoter

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2002 Sep 18
PMID 12235157
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Intracellular calcium levels can have profound effects on muscle biology via alterations in gene expression. In particular, intracellular calcium levels increase during muscle activation and are thought to underlie fast-to-slow shifts in muscle gene expression. In the present work, we determined that increased intracellular calcium has a significant effect on the activity of the adult fast myosin heavy chain (MyHC) promoters in the order of MyHC IIa>> IId/x > IIb. We have identified the pathways by which the calcium signal mediates increased activation of the MyHC IIa promoter. Inhibition of calcineurin or calcium-calmodulin kinase greatly attenuates ionophore-induced activation of the MyHC IIa promoter, whereas protein kinase C inhibitors have no effect. Inhibition and overexpression studies with members of the mitogen-activated protein kinase family reveal roles for MEK1/MEK2 and MEKK1, but not p38 or phosphatidylinositol 3-kinase. Downstream mediators of these effects are the activities of the MEF-2 and NFAT transcription factors, whose binding sites in the MyHC IIa promoter are required for calcium-induced activation of the MyHC IIa promoter.

Citing Articles

Cell Mechanics Regulates the Dynamic Anisotropic Remodeling of Fibril Matrix at Large Scale.

Ouyang M, Hu Y, Chen W, Li H, Ji Y, Qiu L Research (Wash D C). 2025; 6:0270.

PMID: 39882542 PMC: 11776286. DOI: 10.34133/research.0270.


The Effect of Mechanical Stretch on Myotube Growth Suppression by Colon-26 Tumor-Derived Factors.

Halle J, Counts-Franch B, Prince R, Carson J Front Cell Dev Biol. 2021; 9:690452.

PMID: 34395422 PMC: 8363303. DOI: 10.3389/fcell.2021.690452.


Pharmacological activation of SERCA ameliorates dystrophic phenotypes in dystrophin-deficient mdx mice.

Nogami K, Maruyama Y, Sakai-Takemura F, Motohashi N, Elhussieny A, Imamura M Hum Mol Genet. 2021; 30(11):1006-1019.

PMID: 33822956 PMC: 8170845. DOI: 10.1093/hmg/ddab100.


microRNA-mRNA Profile of Skeletal Muscle Differentiation and Relevance to Congenital Myotonic Dystrophy.

Morton S, Sefton C, Zhang H, Dai M, Turner D, Uhler M Int J Mol Sci. 2021; 22(5).

PMID: 33799993 PMC: 7962092. DOI: 10.3390/ijms22052692.


The Failed Clinical Story of Myostatin Inhibitors against Duchenne Muscular Dystrophy: Exploring the Biology behind the Battle.

Rybalka E, Timpani C, Debruin D, Bagaric R, Campelj D, Hayes A Cells. 2020; 9(12).

PMID: 33322031 PMC: 7764137. DOI: 10.3390/cells9122657.